[Postoperative refractory chylothorax which was improved by octreotide acetate]

Riferimento: 
Kyobu Geka. 2012 Mar;65(3):230-3.
Autori: 
Gabe A, Seki M, Taira N, Katsura M, Ishida T, Kang Y, Kubota T, Yamashiro T, Uehara T, Sunagawa T, Ohkubo K.
Fonte: 
Kyobu Geka. 2012 Mar;65(3):230-3.
Anno: 
2012
Azione: 
Octreotide acetato può essere una scelta per il trattamento conservativo postoperatorio del chilotorace refrattario nel carcinoma non a piccole cellule del polmone.
Target: 
Octreotide acetato/carcinoma non a piccole cellule del polmone.

ABSTRACT
A 77-year-old male with chronic hepatitis and liver cirrhosis underwent a right middle-lower lobectomy and lymph node dissection because of non-small cell carcinoma of the lung. On the 1st post-operative day (POD1), a large quantity of chylous pleural effusion was recognized after he initiated oral intake. The diagnosis was postoperative chylothorax. Conservative therapy including a medium chain tryglyceride diet and total parental nutrition were not effective. Considering of the patient's past history, we decided to continue conservative therapy using octreotide acetate on POD7. After administration of the octreotide acetate, the volume of chylous pleural effusion gradually decreased. The chest tube was removed on POD19. Octreotide acetate should be a choice for the conservative treatment of postoperative refractory chylothorax.